MCID: HYP539
MIFTS: 47

Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive malady

Categories: Genetic diseases, Rare diseases, Neuronal diseases, Metabolic diseases

Aliases & Classifications for Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive

About this section

Aliases & Descriptions for Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive:

Name: Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive 52 12
Hyperekplexia 11 23 24 25 54 27 50
Hereditary Hyperekplexia 11 48 25 54
Kok Disease 11 48 54 70
Startle Disease, Familial 23 48 24
Hyperekplexia, Hereditary 23 24 27
Familial Startle Disease 11 54 70
Stiff-Baby Syndrome 48 25 70
Startle Syndrome 23 24 25
Sthe 48 25 70
Congenital Stiff-Person Syndrome 25 70
Congenital Stiff-Man Syndrome 25 70
Congenital Stiff Man Syndrome 11 54
Exaggerated Startle Reaction 48 70
 
Hereditary Hyperexplexia 54 68
Hyperekplexia Hereditary 1 Autosomal Dominant or Recessive 70
Stiff-Person Syndrome, Congenital 48
Stiff-Man Syndrome, Congenital 48
Startle Reaction, Exaggerated 48
Hereditary Hyperexplexia 1 70
Hyperexplexia Hereditary 48
Familial Hyperekplexia 25
Stiff-Person Syndrome 68
Stiff Baby Syndrome 54
Hyperekplexia 1 70
Startle Disease 11
Hkpx1 70

Characteristics:

Orphanet epidemiological data:

54
hyperekplexia:
Inheritance: Autosomal dominant,Autosomal recessive; Prevalence: <1/1000000 (Worldwide); Age of onset: Infancy,Neonatal

HPO:

64
hyperekplexia, hereditary 1, autosomal dominant or recessive:
Inheritance: autosomal dominant inheritance, autosomal recessive inheritance
Onset and clinical course: infantile onset

GeneReviews:

23
Penetrance: overall, the penetrance of hyperekplexia is 100%; however, in one family a mother who had the same mutation as her two children was asymptomatic [kwok et al 2001]...


Classifications:



External Ids:

OMIM52 149400
Disease Ontology11 DOID:0060695
ICD1030 G25.8
Orphanet54 ORPHA3197
ICD10 via Orphanet31 G25.8
MedGen37 C1835614

Summaries for Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive

About this section
OMIM:52 Hyperekplexia is an early-onset neurologic disorder characterized by an exaggerated startle response to sudden,... (149400) more...

MalaCards based summary: Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive, also known as hyperekplexia, is related to hyperekplexia 2, autosomal recessive and hyperekplexia 3, and has symptoms including hypertonia, hyperreflexia and limitation of joint mobility. An important gene associated with Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive is GLRA1 (Glycine Receptor Alpha 1), and among its related pathways are Ligand-gated ion channel transport and Ion channel transport. Affiliated tissues include bone, and related mouse phenotypes are muscle and behavior/neurological.

Disease Ontology:11 A nervous system disease characterized by an exaggerated startle response to sudden, unexpected auditory or tactile stimuli and hypertonia.

UniProtKB/Swiss-Prot:70 Hyperekplexia 1: A neurologic disorder characterized by muscular rigidity of central nervous system origin, particularly in the neonatal period, and by an exaggerated startle response to unexpected acoustic or tactile stimuli.

Genetics Home Reference:25 Hereditary hyperekplexia is a condition in which affected infants have increased muscle tone (hypertonia) and an exaggerated startle reaction to unexpected stimuli, especially loud noises. Following the startle reaction, infants experience a brief period in which they are very rigid and unable to move. During these rigid periods, some infants stop breathing, which, if prolonged, can be fatal. This condition may explain some cases of sudden infant death syndrome (SIDS), which is a major cause of unexplained death in babies younger than 1 year. Infants with hereditary hyperekplexia have hypertonia at all times, except when they are sleeping.

NIH Rare Diseases:48 Hereditary hyperekplexia is an inherited condition that is usually evident in infants. Symptoms include increased muscle tone (hypertonia) and an exaggerated startle reaction to unexpected stimuli, especially loud noises. Following the startle reaction, infants experience a brief period in which they are very rigid and unable to move. During these rigid periods, some infants stop breathing, which can be fatal. This condition may explain some cases of sudden infant death syndrome (SIDS). Stiffness typically fade by age 1. However, older individuals with this condition may still startle easily and have periods of rigidity. Others may have a low tolerance for crowded places and loud noises. This condition has different inheritance patterns and is associated with mutations in at least five genes. Treatment is mainly with the use of the drug clonazepam which is very effective in reducing symptoms. Last updated: 2/19/2016

Wikipedia:71 Hyperekplexia (\"exaggerated surprise\") is a neurologic disorder classically characterised by... more...

GeneReviews for NBK1260

Related Diseases for Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive

About this section

Diseases in the Sporadic Hyperekplexia family:

Hyperekplexia 2, Autosomal Recessive hyperekplexia, hereditary 1, autosomal dominant or recessive
Hyperekplexia 3 Hyperekplexia 1
Arhgef9-Related Hyperekplexia Glra1-Related Hyperekplexia
Glrb-Related Hyperekplexia Gphn-Related Hyperekplexia
Slc6a5-Related Hyperekplexia

Diseases related to Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 35)
idRelated DiseaseScoreTop Affiliating Genes
1hyperekplexia 2, autosomal recessive12.1
2hyperekplexia 312.1
3hyperekplexia 112.0
4sporadic hyperekplexia11.9
5arhgef9-related hyperekplexia11.7
6glra1-related hyperekplexia11.7
7glrb-related hyperekplexia11.7
8gphn-related hyperekplexia11.7
9slc6a5-related hyperekplexia11.7
10epileptic encephalopathy, early infantile, 811.5
11molybdenum cofactor deficiency11.1
12stiff-person syndrome11.0
13epileptic encephalopathy, early infantile, 1710.7
14spastic paraparesis9.9
15spasticity9.9
16deafness, autosomal recessive 1019.9GLRA1, GPHN
17glycine encephalopathy9.9GARS, SLC6A5
18microcephaly9.8
19epilepsy9.8
20neuronitis9.8
21encephalopathy9.8
22cryptogenic organizing pneumonia9.7GLRA1, GLRB
23sudden infant death syndrome9.7
24sulfite oxidase deficiency9.7
25sleep apnea9.7
26obstructive sleep apnea9.7
27inguinal hernia9.7
28status epilepticus9.7
29cerebritis9.7
30muscular dystrophy9.7
31intellectual disability9.7
32startle epilepsy9.7
33complement component deficiency9.6GLRA1, GPHN
34myd88 deficiency9.4GLRA1, GLRB, GPHN
35ipex syndrome7.9ARHGEF9, GARS, GLRA1, GLRB, GPHN, SLC6A5

Graphical network of the top 20 diseases related to Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive:



Diseases related to hyperekplexia, hereditary 1, autosomal dominant or recessive

Symptoms & Phenotypes for Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive

About this section

Symptoms by clinical synopsis from OMIM:

149400

Clinical features from OMIM:

149400

Human phenotypes related to Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive:

 64 (show all 20)
id Description HPO Frequency HPO Source Accession
1 hypertonia64 hallmark (90%) HP:0001276
2 hyperreflexia64 hallmark (90%) HP:0001347
3 limitation of joint mobility64 hallmark (90%) HP:0001376
4 incoordination64 hallmark (90%) HP:0002311
5 involuntary movements64 hallmark (90%) HP:0004305
6 gait disturbance64 typical (50%) HP:0001288
7 umbilical hernia64 typical (50%) HP:0001537
8 sleep disturbance64 typical (50%) HP:0002360
9 seizures64 occasional (7.5%) HP:0001250
10 joint dislocation64 occasional (7.5%) HP:0001373
11 abnormality of the hip bone64 occasional (7.5%) HP:0003272
12 cognitive impairment64 occasional (7.5%) HP:0100543
13 inguinal hernia64 HP:0000023
14 myoclonus64 HP:0001336
15 apnea64 HP:0002104
16 exaggerated startle response64 HP:0002267
17 frequent falls64 HP:0002359
18 hypokinesia64 HP:0002375
19 hip dislocation64 HP:0002827
20 aspiration64 HP:0002835

UMLS symptoms related to Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive:


muscle rigidity, muscle spasticity, torticollis, cogwheel rigidity, opisthotonus, hyperexplexia, drop attack, increased sweating, abnormal muscle tone, anal sphincter atony, nuchal rigidity, myoclonus

MGI Mouse Phenotypes related to Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053699.2GARS, GLRA1, GLRB, SLC6A5
2MP:00053867.9ARHGEF9, GARS, GLRA1, GLRB, GPHN, SLC6A5
3MP:00036317.1ARHGEF9, GARS, GLRA1, GLRB, GPHN, SLC6A5

Drugs & Therapeutics for Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive

About this section

Drugs for Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 12)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
rituximabapprovedPhase 21654174722-31-710201696
Synonyms:
AntiCD20
IDEC-102
IDEC-C2B8
 
Ig gamma-1 chain C region
MabThera
Mabthera
Rituxan
rituximab
2AntibodiesPhase 2, Phase 16045
3ImmunoglobulinsPhase 2, Phase 16045
4Antirheumatic AgentsPhase 210627
5Antibodies, MonoclonalPhase 23795
6Rho(D) Immune GlobulinPhase 1317
7gamma-GlobulinsPhase 1317
8Immunoglobulins, IntravenousPhase 1324
9
Glycineapproved, nutraceutical, vet_approved22656-40-6750
Synonyms:
(1-13c)glycinato
(15N)Glycine
15527_RIEDEL
15527_SIAL
15743-44-9 (mono-potassium salt)
17829-66-2 (cobalt salt)
18875-39-3
2,2-dialkylglycines
2-Aminoacetate
2-Aminoacetic acid
2311-65-1
25718-94-9
29728-27-6 (monoammonium salt)
32817-15-5 (copper salt)
33226_RIEDEL
33226_SIAL
33242-26-1 (calcium salt)
35947-07-0 (calcium salt (2:1))
410225_SIAL
50046_FLUKA
50046_SIGMA
513-29-1 (sulfate (3:1))
52955-63-2
56-40-6
57678-19-0
6000-43-7 (hydrochloride)
6000-44-8 (mono-hydrochloride salt)
63183-41-5 (hydrochloride hydrogen carbonate)
71295-98-2 (phosphate (1:1))
7490-95-1 (hydrochloride (2:1)
7490-95-1 (hydrochloride (2:1))
7575-55-5
848646-45-7
87867-94-5
AB-131/40217813
AB1002628
AC1L19XW
AC1Q28JW
AC1Q53O0
AI3-04085
AKOS000119626
AMINOACETIC ACID 1.5% IN PLASTIC CONTAINER
AR-1A0345
AR-1A0532
Acide aminoacetique
Acide aminoacetique [INN-French]
Acido aminoacetico
Acido aminoacetico [INN-Spanish]
Acidum aminoaceticum
Acidum aminoaceticum [INN-Latin]
Aciport
Amino-Acetate
Amino-Acetic acid
Aminoacetate
Aminoacetic acid
Aminoazijnzuur
Aminoessigsaeure
Aminoethanoate
Aminoethanoic acid
Amitone
B72BA06C-60E9-4A83-A24A-A2D7F465BB65
BPBio1_001222
Biomol-NT_000195
C00037
CCRIS 5915
CHEBI:15428
CHEBI:15705
CHEBI:16228
CHEMBL773
CID750
CPD-8569
Corilin
D00011
DB00145
EINECS 200-272-2
 
FEMA No. 3287
FT-0083159
G
G0099
G0317
G5417_SIGMA
G5523_SIGMA
G7126_SIGMA
G7403_SIGMA
G8790_SIGMA
G8898_SIGMA
GLY (IUPAC abbrev)
GLYCINE 1.5% IN PLASTIC CONTAINER
GLYCINE, ACS
Glicina
Glicina [INN-Spanish]
Glicoamin
Gly
Glycin
Glycine
Glycine (JP15/USP)
Glycine [INN]
Glycine iron sulphate (1:1)
Glycine, homopolymer (VAN)
Glycine, labeled with carbon-14
Glycine, non-medical
Glycine-UL-14C hydrochloride
Glycinum
Glycinum [INN-Latin]
Glycocoll
Glycolixir
Glycosthene
Glykokoll
Glyzin
Gyn-Hydralin
Gyn-hydralin
H-Gly-OH
H2N-CH2-COOH
HSDB 495
Hampshire glycine
Hgly
InChI=1/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5
KST-1A2919
KST-1A8102
L-Glycine
L-alpha-amino acids
L001246
LS-218
Leimzucker
MolPort-000-871-607
NCGC00024503-01
NCGC00024503-02
NChemBio.2007.13-comp1
NSC 25936
NSC25936
P8791_SIGMA
Padil
Polyglycine II
S04-0135
Sucre de gelatine
Tocris-0219
UNII-TE7660XO1C
W328707_ALDRICH
WLN: Z1VQ
aminoacetic acid
an alpha amino acid ester
bmse000089
gly
glycine
nchem.554-comp2
nchembio.121-comp9
nchembio.145-comp33
nchembio.198-comp12
nchembio.265-comp9
nchembio.266-comp30
polyglycine
10Autoantibodies126
11Neurotransmitter Agents17734
12Glutamic AcidNutraceutical214

Interventional clinical trials:

idNameStatusNCT IDPhase
1Rituximab to Treat Stiff Person SyndromeCompletedNCT00091897Phase 2
2Stem Cell Transplantation for Stiff Person Syndrome (SPS)RecruitingNCT02282514Phase 1, Phase 2
3Intravenous Immunoglobulin (IVIg) for the Treatment of Stiff-Man Syndrome (SMS)CompletedNCT00001550Phase 1
4Cause, Development, and Progression of Stiff-Person SyndromeCompletedNCT00030940
5Effects of Mutations of the Glycine Gene Associated With Hyperekplexia on Central Pain ProcessingTerminatedNCT01476514

Search NIH Clinical Center for Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive

Genetic Tests for Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive

About this section

Genetic tests related to Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive:

id Genetic test Affiliating Genes
1 Hyperekplexia27 24 SLC6A5
2 Hyperekplexia Hereditary27

Anatomical Context for Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive

About this section

MalaCards organs/tissues related to Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive:

36
Bone

Publications for Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive

About this section

Variations for Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive

About this section

UniProtKB/Swiss-Prot genetic disease variations for Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive:

70 (show all 18)
id Symbol AA change Variation ID SNP ID
1GLRA1p.Ile272AsnVAR_000296rs121918409
2GLRA1p.Gln294HisVAR_000297rs121918411
3GLRA1p.Arg299LeuVAR_000298rs121918408
4GLRA1p.Arg299GlnVAR_000299rs121918408
5GLRA1p.Lys304GluVAR_000300rs121918412
6GLRA1p.Tyr307CysVAR_000301rs121918410
7GLRA1p.Pro278ThrVAR_010112rs121918413
8GLRA1p.Arg280HisVAR_010113rs281864918
9GLRA1p.Arg428HisVAR_010114rs281864919
10GLRA1p.Arg93TrpVAR_075418rs199547699
11GLRA1p.Arg100CysVAR_075419
12GLRA1p.Arg246TrpVAR_075420rs751659671
13GLRA1p.Gln254GluVAR_075421
14GLRA1p.Pro258SerVAR_075422
15GLRA1p.Val308MetVAR_075423
16GLRA1p.Leu319ProVAR_075424
17GLRA1p.Asp424AlaVAR_075425
18GLRA1p.Arg450HisVAR_075426rs200130685

Clinvar genetic disease variations for Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive:

5 (show all 23)
id Gene Variation Type Significance SNP ID Assembly Location
1GLRA1NM_001146040.1(GLRA1): c.896G> T (p.Arg299Leu)SNVPathogenicrs121918408GRCh37Chr 5, 151230967: 151230967
2GLRA1NM_001146040.1(GLRA1): c.896G> A (p.Arg299Gln)SNVPathogenicrs121918408GRCh37Chr 5, 151230967: 151230967
3GLRA1NM_001146040.1(GLRA1): c.815T> A (p.Ile272Asn)SNVPathogenicrs121918409GRCh37Chr 5, 151231048: 151231048
4GLRA1NM_001146040.1(GLRA1): c.920A> G (p.Tyr307Cys)SNVPathogenicrs121918410GRCh37Chr 5, 151208621: 151208621
5GLRA1NM_001146040.1(GLRA1): c.882G> C (p.Gln294His)SNVPathogenicrs121918411GRCh37Chr 5, 151230981: 151230981
6GLRA1NM_001146040.1(GLRA1): c.910A> G (p.Lys304Glu)SNVPathogenicrs121918412GRCh37Chr 5, 151230953: 151230953
7GLRA1NM_001146040.1(GLRA1): c.832C> A (p.Pro278Thr)SNVPathogenicrs121918413GRCh37Chr 5, 151231031: 151231031
8GLRA1NM_001146040.1(GLRA1): c.690C> A (p.Tyr230Ter)SNVPathogenicrs121918415GRCh37Chr 5, 151234608: 151234608
9GLRA1NM_001146040.1(GLRA1): c.862G> A (p.Val288Met)SNVPathogenicrs121918416GRCh37Chr 5, 151231001: 151231001
10GLRA1NM_001146040.1(GLRA1): c.777C> G (p.Ser259Arg)SNVPathogenicrs121918417GRCh37Chr 5, 151231086: 151231086
11GLRA1NM_001146040.1(GLRA1): c.(?_-287)_(912+?)deldeletionPathogenicChr na, -1: -1
12GLRA1NM_001146040.1(GLRA1): c.971C> A (p.Ser324Ter)SNVPathogenicrs121918418GRCh37Chr 5, 151208570: 151208570
13GLRA1NM_001146040.1(GLRA1): c.884G> A (p.Ser295Asn)SNVPathogenicrs267606848GRCh37Chr 5, 151230979: 151230979
14GLRA1NM_000171.3(GLRA1): c.1108G> A (p.Gly370Ser)SNVPathogenicrs116474260GRCh37Chr 5, 151202476: 151202476
15GLRA1NM_001146040.1(GLRA1): c.299G> A (p.Arg100His)SNVPathogenicrs281864914GRCh37Chr 5, 151239523: 151239523
16GLRA1NM_001146040.1(GLRA1): c.737G> A (p.Arg246Gln)SNVPathogenicrs281864916GRCh37Chr 5, 151231126: 151231126
17GLRA1NM_001146040.1(GLRA1): c.801G> C (p.Trp267Cys)SNVPathogenicrs281864917GRCh37Chr 5, 151231062: 151231062
18GLRA1NM_001146040.1(GLRA1): c.892T> A (p.Ser298Thr)SNVPathogenicrs281864920GRCh37Chr 5, 151230971: 151230971
19GLRA1NM_001146040.1(GLRA1): c.920A> C (p.Tyr307Ser)SNVPathogenicrs121918410GRCh37Chr 5, 151208621: 151208621
20GLRA1NM_001146040.1(GLRA1): c.921delT (p.Tyr307Terfs)deletionPathogenicrs281864921GRCh37Chr 5, 151208620: 151208620
21GLRA1NM_000171.3(GLRA1): c.298delC (p.Arg100Alafs)deletion, CompoundHeterozygotePathogenicrs281864915GRCh37Chr 5, 151239524: 151239524
22GLRA1NM_000171.3(GLRA1): c.(?_-287)_697+?deldeletionPathogenicGRCh38Chr 5, 151855040: 151924836
23GPHNNM_020806.4(GPHN): c.28A> T (p.Asn10Tyr)SNVPathogenicrs121908539GRCh37Chr 14, 66975273: 66975273

Copy number variations for Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive from CNVD:

6
id CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
11949775147200000152100000DeletionGLRA1Hyperekplexia

Expression for genes affiliated with Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive

About this section
Search GEO for disease gene expression data for Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive.

Pathways for genes affiliated with Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive

About this section

GO Terms for genes affiliated with Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive

About this section

Cellular components related to Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cell junctionGO:00300549.6GLRA1, GLRB, GPHN
2dendriteGO:00304259.5GLRA1, GLRB, GPHN
3postsynaptic membraneGO:00452118.9GLRA1, GLRB, GPHN

Biological processes related to Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive according to GeneCards Suite gene sharing:

(show all 14)
idNameGO IDScoreTop Affiliating Genes
1acrosome reactionGO:000734010.2GLRA1, GLRB
2adult walking behaviorGO:000762810.2GLRA1, GLRB
3chloride transmembrane transportGO:190247610.2GLRA1, GLRB
4ion transportGO:000681110.1GLRA1, GLRB
5neuromuscular processGO:005090510.1GLRA1, GLRB
6gamma-aminobutyric acid receptor clusteringGO:009711210.0GLRB, GPHN
7neuropeptide signaling pathwayGO:000721810.0GLRA1, GLRB
8protein heterooligomerizationGO:005129110.0GLRA1, GLRB
9regulation of membrane potentialGO:00423919.9GLRA1, GLRB
10righting reflexGO:00600139.8GLRA1, GLRB
11chemical synaptic transmissionGO:00072689.7GLRA1, GLRB, SLC6A5
12startle responseGO:00019649.6GLRA1, GLRB
13ion transmembrane transportGO:00342209.3ARHGEF9, GLRA1, GLRB
14synaptic transmission, glycinergicGO:00600129.0GLRA1, GLRB, SLC6A5

Molecular functions related to Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1extracellular-glycine-gated chloride channel activityGO:00169349.8GLRA1, GLRB
2extracellular-glycine-gated ion channel activityGO:00169339.7GLRA1, GLRB
3glycine bindingGO:00165949.4GLRA1, GLRB

Sources for Hyperekplexia, Hereditary 1, Autosomal Dominant or Recessive

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet